Naason Science
Naason Science
  • Home
  • Research
    • Preclinical Research
    • CNS Models
    • Pain Models
    • Endometriosis Models
    • Oncology Models
    • Ophthalmology Models
    • Orthopedic Models
    • Metabolic Disease Models
    • Psychiatric Models
    • In Vitro
    • Safety & Toxicity Studies
  • News
  • Careers
    • Naason Team
    • Join the team
  • Investors
  • Contact
  • More
    • Home
    • Research
      • Preclinical Research
      • CNS Models
      • Pain Models
      • Endometriosis Models
      • Oncology Models
      • Ophthalmology Models
      • Orthopedic Models
      • Metabolic Disease Models
      • Psychiatric Models
      • In Vitro
      • Safety & Toxicity Studies
    • News
    • Careers
      • Naason Team
      • Join the team
    • Investors
    • Contact
  • Home
  • Research
    • Preclinical Research
    • CNS Models
    • Pain Models
    • Endometriosis Models
    • Oncology Models
    • Ophthalmology Models
    • Orthopedic Models
    • Metabolic Disease Models
    • Psychiatric Models
    • In Vitro
    • Safety & Toxicity Studies
  • News
  • Careers
    • Naason Team
    • Join the team
  • Investors
  • Contact

CNS Models

Naason Science offers tools to study CNS Diseases in rodents and larger animals. From in vitro systems to large and small animal in vivo models Naason Science provides a tool box of state-of-the-art technologies that allow for rapid and effective testing of preclinical drug candidates.


Naason Science scientists have expertise in all major CNS diseases and tools to develop novel therapies for rare and orphan diseases. 

Naason CNS Models and Areas of Expertise

Parkinson’s Disease

Alzheimer’s Disease

Alzheimer’s Disease

  • α-synuclein pff-induced PD
  • 6-OHDA
  • MPTP
  • mthy1 α-syn TG

Learn more

Alzheimer’s Disease

Alzheimer’s Disease

Alzheimer’s Disease

  • 5xFAD
  • APP/PS1
  • P3O1S Tau
  • Aβ injection
  • scopolamine

Contact for more info

Huntington’s Disease

Alzheimer’s Disease

Multiple Sclerosis Models

  • R6/2 TG mice
  • Q175 KI mice

Learn more

Multiple Sclerosis Models

Amyotrophic Lateral Sclerosis

Multiple Sclerosis Models

  • EAE (MOG & PLP)
  • Cuprizone

Contact for more info

Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

  • SOD1 Mouse

Learn more

Duchenne Muscular Dystrophy

Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

  • MDX in mice

Learn more

Spinocerebellar Ataxia

Stroke & Associated Conditions

Spinocerebellar Ataxia

  • CLN3 Mouse

Contact for more info

Batten Disease

Stroke & Associated Conditions

Spinocerebellar Ataxia

  • SCA 3
  • dystonia

Contact for more info

Stroke & Associated Conditions

Stroke & Associated Conditions

Stroke & Associated Conditions

  • pMCAO
  • tMCAO

Contact for more info

Advanced Parkinson´s disease modelling α-syn-pff injection

Alpha-synuclein (α-syn) protofibrils facilitate the formation of protein aggregates in the brain Parkinson´s disease has been extensively modelled in rodents. However, the ability to reliably recreate the protein misfolding, inflammatory responses, psychiatric and motor symptoms of PD have been hard to recreate. This model facilitates a quicker induction of α-syn aggregates in the brain of the rat and is analogous to that which occurs in the human. 


Home Cage / Group Housed Analysis Behavioural Phenotypes

  • Total Moving Distance (mm)
  • Total Moving Time (s)
  • Separation/Isolation Distance (mm)
  • Isolated Time (s)
  • Thigmotactic Time (s)
  • In Center Zone Time (s)
  • Drinking Time (s)

Download PDF >>>

MPTP Model of Parkinson’s disease

  • MPTP administration induces symptoms of Parkinson’s disease by destroying dopaminergic neurons in the substantia nigra of the brain
  • The Model is fully validated by Naason Science
  • Acute and chronic paradigms are validated and available
  • Validated under all administration routes: IP, IT, SC, ICV, IV
  • Grip strength, Pole test, and active staining of dopaminergic neurons (Tyrosine hydroxylase)

Download PDF >>>

R6/2 Transgenic Mouse Model of Huntington´s Disease

R6/2 mouse, which expresses mutant human exon 1 HTT was the first genetically modified mouse line produced and has been the most extensively studied and utilized mouse model of HD.​

  • Model is fully validated by Naason Science
  • Licensed for 3rd party CRO use (KCL)
  • 20 years of experience with the R6/2 **
  • Validated with all administration routes (IP, PO, SC, IP, IM, ICV, IT)
  • Studies of Behavior and Cognition
  • Studies of Muscle Function, Motor Activity and Gait
  • In-house breeding programs available

Naason Science model assays:

  • ​Grip Strength
  • ​RotaRod
  • Home cage rearing
  • Home cage locomotor activity
  • Imaging (MRI/MRS, PET-SPECT / CT)
  • ​Histology / Stereology

Download PDF >>>

TG Mouse Model of Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic lateral sclerosis (ALS) is a progressive nervous system disease that affects nerve cells in the brain and spinal cord, causing loss of muscle control. Naason Science has validated the transgenic SOD1-G93A Model of ALS. SOD1 mice exhibit a phenotype similar to ALS in humans and are the most widely used animal model in ALS Drug Discovery Studies.



Download PDF >>>

Naason´s MDX Model of Duchenne Muscular Dystrophy

MDX mouse (on a C57BL/10ScSn-Dmdmdx/J) is a the most highly used model for the study of DMD.

Naason Science has completed validation of it’s MDX mouse model for the study of DMD, the model paradigm has a complete functional and behavioral battery as well as imaging (MRI) and histological analysis of limb muscles, diaphragm and heart. In addition, gene expression rounds out the paradigm.


Download PDF >>>

CNS In Vitro Platform

  • Primary Hipp Neurons
  • Primary Cortical Neurons
  • Primary DA Neurons
  • SN4741 DA Neuronal Cell Lines


  • In vitro AD, PD, HD
  • Oxidative Stress (ROS)
  • Mitochondrial Function
  • Neuronal Outgrowth
  • Cell Death


  • High Content Screening
  • HTS

Learn more about Naason in vitro models

For more information please

Contact us

© 2023 Naason Science Inc. All rights reserved.

  • Home
  • Preclinical Research
  • News
  • Areas of Expertise
  • Privacy & Terms
  • Contact

Welcome to Naason Science website!

Our website uses cookies. By continuing to use this site, you accept our use of cookies.

DeclineAccept